Tudor Investment Corp’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$263K Buy
2024
Q3
Sell
2024
Q2
$566K Buy
2022
Q4
Sell
2022
Q3
$56K Sell
2022
Q2
$63K Sell
2022
Q1
$98K Hold
2021
Q4
$117K Hold
2021
Q3
$212K Buy